Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tetanus toxin-McMaster University-diphtheria-pertussis-tetanus-measles-mumps
- Development stage
- Unknown
- Lead developer
- McMaster University
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Oral
01
Overview
The drug name "tetanus toxin-McMaster University-diphtheria-pertussis-tetanus-measles-mumps" refers to a specific set of five homeopathic nosodes—Diphtherinum, Pertussinum, Tetanotxicum, Morbilinum, and Ourlianum—evaluated in a randomized controlled trial at McMaster University (NCT00278434). These preparations are intended as homeopathic alternatives to conventional vaccines for diphtheria, pertussis, tetanus, measles, and mumps. Homeopathic nosodes are prepared through the serial dilution and succussion of biological materials, such as toxins or diseased tissue, following the principle of "like cures like." The McMaster study aimed to compare the immunological response (antibody production) of these homeopathic preparations against conventional vaccines (Tdap and MMR) and placebos in healthy young adults. Results from the trial indicated that the homeopathic nosodes failed to elicit a significant antibody response compared to placebo, whereas the conventional vaccines performed as expected.
- Brand names
- DiphtherinumPertussinumTetanotxicumMorbilinumOurlianum
- Other names
- homeopathic nosode combination (McMaster University)homeopathic vaccinesnosodes
Beyond the preview
Go deeper on tetanus toxin-McMaster University-diphtheria-pertussis-tetanus-measles-mumps.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tetanus toxin-McMaster University-diphtheria-pertussis-tetanus-measles-mumps.